Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Hanawa

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Genetics and Metabolism|December 19, 2008
Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal periodKoichi Ogawa, Yukihiko Hirai, Masamichi Ishizaki, et al.
Blood|November 2, 2002
The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy numberDerek A Persons, Phillip W Hargrove, Esther R Allay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2007
Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vectorMarguerite V Evans-Galea, Matthew M Wielgosz, Hideki Hanawa, et al.
Blood|June 17, 2004
Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemiaHideki Hanawa, Phillip W Hargrove, Steven Kepes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemiaKoiti Inokuchi, Hiroki Yamaguchi, Hideki Hanawa, et al.
Experimental Hematology|May 26, 2009
Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expressionHiroki Yamaguchi, Hideki Hanawa, Naoya Uchida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2007
Systemic cancer gene therapy using adeno-associated virus type 1 vector expressing MDA-7/IL24Ichiro Tahara, Koichi Miyake, Hideki Hanawa, et al.
Human Gene Therapy|October 20, 2007
Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoproteinShigeki Kato, Ken-ichi Inoue, Kenta Kobayashi, et al.
Blood|March 29, 2003
Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cellsDerek A Persons, Esther R Allay, Nobukuni Sawai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2008
Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cellsPhillip W Hargrove, Steven Kepes, Hideki Hanawa, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Genetics and Metabolism|December 19, 2008
Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal periodKoichi Ogawa, Yukihiko Hirai, Masamichi Ishizaki, et al.
Blood|November 2, 2002
The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy numberDerek A Persons, Phillip W Hargrove, Esther R Allay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2007
Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vectorMarguerite V Evans-Galea, Matthew M Wielgosz, Hideki Hanawa, et al.
Blood|June 17, 2004
Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemiaHideki Hanawa, Phillip W Hargrove, Steven Kepes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemiaKoiti Inokuchi, Hiroki Yamaguchi, Hideki Hanawa, et al.
Experimental Hematology|May 26, 2009
Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expressionHiroki Yamaguchi, Hideki Hanawa, Naoya Uchida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2007
Systemic cancer gene therapy using adeno-associated virus type 1 vector expressing MDA-7/IL24Ichiro Tahara, Koichi Miyake, Hideki Hanawa, et al.
Human Gene Therapy|October 20, 2007
Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoproteinShigeki Kato, Ken-ichi Inoue, Kenta Kobayashi, et al.
Blood|March 29, 2003
Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cellsDerek A Persons, Esther R Allay, Nobukuni Sawai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2008
Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cellsPhillip W Hargrove, Steven Kepes, Hideki Hanawa, et al.
Pageof 3